House Bill
|
779
|
An Act to protect 340B providers in the MassHealth program
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
819
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
868
|
An Act enhancing health care market oversight and pharmaceutical access
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
809
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
House Bill
|
1
|
An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1107
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1227
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
House Bill
|
1234
|
An Act relative to pharmacy benefit managers
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
2472
|
An Act protecting patient safety regarding non-FDA approved drugs
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1497
|
An Act protecting patient safety regarding non-FDA approved drugs
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
4001
|
An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Executive
|
Group Insurance Commission (GIC) (Executive Office for Administration and Finance)
|
Advocacy on Behalf of Lilly
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1274
|
An Act prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program
|
Neutral
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |